Hartman Institute for Therapeutic Organ Regeneration

With a generous gift of $10 million from Board of Fellows member Alan Hartman and his wife, Kim, Weill Cornell Medicine has established a multidisciplinary research institute to advance organ regeneration and repair.

The Hartman Institute for Therapeutic Organ Regeneration expands the frontiers of stem cell-based research and organoid development, creating a hub within Weill Cornell Medicine’s Division of Regenerative Medicine that will facilitate collaboration among researchers, clinicians, surgeons and entrepreneurs. Scientists in the division have already devised game-changing technologies to fully realize the promise of tissue-specific organoids for repairing injured and malfunctioning organs – and with the support of the Hartman gift, Weill Cornell Medicine will work to translate those discoveries to patient care.

Priority areas for the Hartman Institute will include gastrointestinal diseases, pulmonary diseases, cardiovascular dysfunction, neurological disorders and stroke, and diseases affecting the metabolic system, with the recruitment of specialists in these disciplines who will engineer organoids for regeneration, with a goal of making this therapy accessible to all patients.

The Hartman Institute is lead by Dr. Shahin Rafii, chief of the Division of Regenerative Medicine in the Joan and Sanford I. Weill Department of Medicine, the Arthur B. Belfer Professor in Genetic Medicine, professor of medicine and of reproductive medicine, and director of the Ansary Stem Cell Institute.